Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/21/2010US7855179 Template-fixed peptidomimetics with antimicrobial activity
12/21/2010US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors
12/21/2010US7855177 Methods and kits for preventing hypoglycemia
12/21/2010US7855176 Periodically administering to a human patient afflicted with relapsing-remitting multiple sclerosis (RRMS) a subcutaneous injection of 0.5 ml of an aqueous solution of 20 mg glatiramer acetate (Copaxone") and 20 mg mannitol; less pain at injection site; antiagglomerants; enzyme inhibitors; drug delivery
12/21/2010US7855175 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists
12/21/2010US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/21/2010US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
12/21/2010US7855063 Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof
12/21/2010US7855058 Human cyclin-dependent kinase (hPNQALRE)
12/21/2010US7855052 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
12/21/2010US7854937 Flavivirus fusion inhibitors
12/21/2010US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854929 using collagenase injections in dissolving and lysing a collagenase septa network to treat carpal tunnel, plantar fasciitis and lateral epicondylitis conditions; non-surgical treatment of CTS, of collagenous elbow and/or knee joint adhesions, and to dissolve fibrous adhesions in a sole of a foot
12/21/2010US7854927 reducing a symptom of psoriasis by administering a composition comprising Bacillus coagulans bacteria in an amount effective to reduce serum TNF- alpha levels; skin disorders
12/21/2010US7854753 to cellular surfaces without damage; transdermal, transmembrane; with solvent, gelling agent, and photocatalyst has a band gap energy of 2.9 eV to 3.2 e
12/21/2010US7854717 uses ultrapheresis, refined to remove compounds of less than 120,000 daltons molecular weight, followed by administration of replacement fluid, to stimulate the patient's immune system to attack solid tumors
12/21/2010CA2602926C Non-protein stabilized clostridial toxin pharmaceutical compositions
12/21/2010CA2468374C Glp-1 derivatives
12/21/2010CA2464130C Mch antagonists for the treatment of obesity
12/21/2010CA2460956C Tetrapeptide derivative crystals
12/21/2010CA2457145C Assay method for alzheimer's disease
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2433037C Sustained-release preparation
12/21/2010CA2412004C Glucagon-like peptide-1 analogs
12/21/2010CA2411981C Urokinase inhibitors
12/21/2010CA2366674C Pharmaceutical compositions comprising erythropoietin for treatment of cancer
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/21/2010CA2322215C Matrix protein compositions for wound healing
12/21/2010CA2294924C Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2223833C Compounds and peptides that bind to the erythropoietin receptor
12/21/2010CA2220753C Novel peptides and compositions which modulate apoptosis
12/21/2010CA2214406C Use of penciclovir for the treatment of human herpes-virus-8
12/21/2010CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor
12/21/2010CA2161351C Transgenic non-human animals capable of producing heterologous antibodies
12/19/2010CA2670301A1 Inhibition of metastasis using activated protein c
12/16/2010WO2010144904A1 Use of lcat for treating anemia and red blood cell dysfunction
12/16/2010WO2010144874A2 Clusterin pharmaceuticals and treatment methods using the same
12/16/2010WO2010144821A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
12/16/2010WO2010144800A1 Methods and compositions for promoting a cell-mediated immune response
12/16/2010WO2010144789A2 Diketopiperazine microparticles with defined specific surface areas
12/16/2010WO2010144785A2 Diketopiperazine microparticles with defined isomer contents
12/16/2010WO2010144742A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010WO2010144721A2 Model systems and treatment regimes for treatment of neurological disease
12/16/2010WO2010144711A2 Immunological targeting of pathological tau proteins
12/16/2010WO2010144629A1 Hemoglobin compositions
12/16/2010WO2010144508A1 Glucose-regulating polypeptides and methods of making and using same
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010144452A1 Methods for increasing thermogenic adipocytes
12/16/2010WO2010144231A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010WO2010144038A1 Melanocortin receptor-specific peptides
12/16/2010WO2010143985A1 The application of adenylate kinase to disaggregation and inhibition of aggregation of blood platelets
12/16/2010WO2010143711A1 Wound-covering material
12/16/2010WO2010143708A1 Targeting agent for neovascularization
12/16/2010WO2010143435A1 Vaccine therapy for choroidal neovascularization
12/16/2010WO2010142800A1 Novel applications of hip/pap or derivatives thereof
12/16/2010WO2010142665A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2
12/16/2010WO2010142630A1 Il-17 for use in treating local infections in mammals
12/16/2010WO2010142461A2 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010WO2010142309A1 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010WO2010142296A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
12/16/2010WO2010142293A1 Compounds acting as peptide gap junction modulators, and uses thereof
12/16/2010WO2010142141A1 Neuregulin based methods for treating heart failure
12/16/2010WO2010142060A1 Lhrh antagonist with long potency and low histamine releasing effect
12/16/2010WO2010142058A1 Peptide derivatives with endothelin receptor antagonizing activity, pharmaceutical compositions and uses thereof
12/16/2010WO2010142041A1 Serine rich peptides having antioxidative stress properties
12/16/2010WO2010142040A1 Novel netrin derivatives and uses thereof
12/16/2010WO2010142035A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010WO2010142017A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010WO2010141985A1 Methods of treatment
12/16/2010WO2010141974A1 Therapeutic applications
12/16/2010WO2010123947A3 Silk fibroin hydrogels and uses thereof
12/16/2010WO2010118832A3 Inhibition of the liver enriched protein foxa2 for the treatment of colorectal liver metastases
12/16/2010WO2010099955A8 Protease for wound conditioning and skin care
12/16/2010WO2010086867A3 Peptides, pharmaceutical compositions comprising same and uses thereof
12/16/2010WO2010075067A3 Methods for diagnosing and treating autoimmune disorders
12/16/2010WO2010041241A3 Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding
12/16/2010WO2007146689A9 Stabilized insulin-like growth factor polypeptides
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100318120 Hemostatic material and delivery device
12/16/2010US20100318060 Injection Device With Rotatable Dose Setting
12/16/2010US20100318003 Method and Apparatus for Connective Tissue Treatment
12/16/2010US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field
12/16/2010US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317600 Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of Same
12/16/2010US20100317599 Process for the production of a peptide
12/16/2010US20100317598 Isolated BRCA1 Peptides and Method of Use
12/16/2010US20100317597 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
12/16/2010US20100317596 Serum amyloid p derivatives and their preparation and use
12/16/2010US20100317595 Compositions for enhancing nail growth
12/16/2010US20100317594 Methods for treating breast cancer using NRIF3 related molecules
12/16/2010US20100317593 2,3-dihydro-1h-indene compounds
12/16/2010US20100317592 Chemokine-binding protein and methods of use
12/16/2010US20100317591 Use of lipid conjugates in the treatment of diseases
12/16/2010US20100317590 Regulation of skin characteristics by dickkopf1 (dkk1)
12/16/2010US20100317589 Compositions and methods for treatment of multiple sclerosis
12/16/2010US20100317588 Compositions comprising fibrous polypeptides and polysaccharides
12/16/2010US20100317587 Injectable bone regeneration gel containing bone formation enhancing peptide
1 ... 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 ... 3163